Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CI-1042: Phase I/II

In a Phase I/II trial in 19 evaluable patients with liver metastases and colorectal cancer, the combination

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE